Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
4.610
+0.410 (9.76%)
Nov 21, 2024, 11:02 AM EST - Market open
Telomir Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 137 | - | - | - |
| Enterprise Value | 124 | - | - | - |
| Debt / Equity Ratio | 0.21 | 0.18 | -0.62 | -0.86 |
| Quick Ratio | 1.39 | 0.00 | 0.00 | - |
| Current Ratio | 1.74 | 0.33 | 0.05 | - |
| Return on Equity (ROE) | -1752.69% | -1045.36% | - | - |
| Return on Assets (ROA) | -204.69% | -102.18% | - | - |
| Return on Capital (ROIC) | -243.60% | -132.78% | - | - |
| Buyback Yield / Dilution | -6.65% | -1.77% | - | - |
| Total Shareholder Return | -6.65% | -1.77% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.